Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06990750 · ClinicalTrials.gov registry record · NA

Single Port Insufflation RCT

A NA study, sponsored by University of Chicago.

Completed
Registry status
NA
Development phase
70
Enrollment target

NCT06990750: Completed NA study, sponsored by University of Chicago.

NCT06990750 is a NA study that has completed, run by University of Chicago. The registered enrollment target is 70 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06990750, a NA study, has completed, sponsored by University of Chicago.

COMPLETED
Registry status
NA
Development phase
70 participants
Enrollment target

Study Summary

The goal of this clinical trial is to learn if decreasing insufflation pressure during minimally invasive single port robotic sacrocolpopexy improved postoperative pain without impacting surgeon intraoperative visualization. The main question it aims to answer is: Does minimally decreasing insufflation pressure improve postoperative pain? Researchers will compare standard insufflation pressure (15 mmHg) to experimental insufflation pressure (12 mmHg) to see if it insufflation pressure impacts patient's postoperative pain. Once a participants agrees to participate in our study, they will receive either standard or experimental pressure at the time of surgery. Postoperative pain scores in the postoperative anesthesia care unit and at postoperative day 1 and 14 visits will be recorded. Participants will also be asked to complete the Patient Global Impression of Improvement at the 14 day visit.

Primary Outcome

Immediate after surgery in the post anesthesia care unit (PACU), patients were asked to rate their pain using a 100 point numeric rating scale (0 \[no pain\] to 100 \[worst imaginable pain\]). The PACU nurse routine asked pain score with routine vitals. The median score was recorded.

Interventions

  • PROCEDURE 15 mmHg
  • PROCEDURE 12 mmHg

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2024-04-01
Est. Completion 2025-04-01
Phase NA
University of Chicago

796 total trials

What the finished NCT06990750 record still lists

NCT06990750 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).

The record links to 0 conditions, and to 2 interventions - of which 15 mmHg is the first listed.

NCT06990750 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06990750 about?

NCT06990750 is a clinical study titled "Single Port Insufflation RCT". The goal of this clinical trial is to learn if decreasing insufflation pressure during minimally invasive single port robotic sacrocolpopexy improved postoperative pain without impacting surgeon intraoperative visualization. The main question it aims to answer is: Does minimally decreasing insuffla...

What is the current status of trial NCT06990750?

This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2024-04-01. Estimated completion is 2025-04-01.

What interventions are being tested in trial NCT06990750?

The interventions under investigation include: 15 mmHg (PROCEDURE), 12 mmHg (PROCEDURE).

Who is sponsoring clinical trial NCT06990750?

This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT06990750's enrollment target sits among peer trials

70 1103rd of 2000 higher than 868 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00969111 · 70 participants · NA

    Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy

  • NCT01712620 · 70 participants · Phase 2

    Spironolactone for Pulmonary Arterial Hypertension

  • NCT02143830 · 70 participants · Phase 2

    HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy

  • NCT02601339 · 70 participants

    NIRS Monitoring in Premature Infants

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06990750, the US trial registry maintained by the National Library of Medicine. NCT06990750 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.